| 123Jump Rating: |
|
Underwriters: |
J.P. Morgan
|
| |
|
|
|
| Status: |
Priced |
|
|
| |
| Address: |
One Kendall Square
Suite B7201, Cambridge
|
FiledDate: |
2011-08-19 |
| |
Suite B7201, Cambridge
|
|
|
| |
MA 02139, US
|
Filed Price Range ($): |
|
| |
|
|
|
| Telephone: |
617-441-1000 |
Filed Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Fax: |
1-617-4911386 |
Shares Offered (Millions): |
|
| |
|
|
|
| Websites: |
www.merrimackpharma.com |
Shares Outstanding (Millions): |
|
| |
|
|
|
| Management: |
Gary L. Crocker - Chairman of the Board of Directors
|
IPO Date: |
|
| |
Robert J. Mulroy - President, CEO and Director
|
|
|
| |
William A. Sullivan - CFO and Treasurer
|
Final Offer Price ($): |
$0.00 |
| |
|
|
|
| Industry: |
Pharmaceutical Preparations |
Final Offer Size (Millions of Shares): |
0.00 |
| |
|
|
|
| Employees: |
218 |
Final Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Competitors: |
|
S-1 Forms: |
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
- Avoid 
- Value Gap 
- Short-Term Growth
- Long-Term Growth 
- Long-Term Value 
